China Sxt Pharmaceuticals Stock Analysis

China Stock Analysis Notes

About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.11. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. China SXT Pharmaceuticals recorded a loss per share of 3.53. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 5th of October 2023. China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets in China. The company was founded in 2005 and is headquartered in Taizhou, China. China Sxt operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 88 people. To find out more about China SXT Pharmaceuticals contact Feng Zhou at 86 523 8629 8290 or learn more at https://www.sxtchina.com.

China SXT Pharmaceuticals Investment Alerts

China SXT Pharmaceuticals Upcoming and Recent Events

China Stock Institutional Investors

Note, although China SXT's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

China Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.58 M.

China Profitablity

The company has Profit Margin (PM) of (1.61) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 7.34 %, which suggests for every 100 dollars of sales, it generated a net operating income of $7.34.

Management Efficiency

China SXT Pharmaceuticals has return on total asset (ROA) of (0.0497) % which means that it has lost $0.0497 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2165) %, meaning that it created substantial loss on money invested by shareholders. China SXT's management efficiency ratios could be used to measure how well China SXT manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.14. The current year's Return On Capital Employed is expected to grow to -0.17. At present, China SXT's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 34.3 K, whereas Total Assets are forecasted to decline to about 21.9 M.

Technical Drivers

As of the 22nd of November, China SXT shows the Risk Adjusted Performance of (0.12), mean deviation of 5.08, and Standard Deviation of 6.54. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of China SXT, as well as the relationship between them.

China SXT Pharmaceuticals Price Movement Analysis

China SXT Outstanding Bonds

China SXT Predictive Daily Indicators

China SXT Forecast Models

China SXT's time-series forecasting models are one of many China SXT's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary China SXT's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how China SXT prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling China shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as China SXT. By using and applying China Stock analysis, traders can create a robust methodology for identifying China entry and exit points for their positions.

When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.